Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

CPIX — Fair Value Analysis

CUMBERLAND PHARMACEUTICALS INC

Current: $4.87Price above range

Fair Value Range

Bear Case (25th pct.)

$1.25

-74.3% vs price

Base Case (Median)

$1.35

-72.3% vs price

Bull Case (75th pct.)

$1.51

-69.0% vs price

$1.25$1.35$1.51

◇ = Current price | | Bear | Base | Bull

Method Breakdown

Method	Est. Value	vs Price	Weight
DCF (Discounted Cash Flow)	$1.16	-76.2%	High (40%)
EV/EBITDA	$1.67	-65.8%	Medium (20%)
EV/FCF	$1.35	-72.3%	Medium (20%)

Interpretation

Based on 3 out of 7 methods, CPIX appears overvalued at the current price of $4.87. The base case fair value of $1.35 implies 72.3% downside.

Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.